Search
for
Sort by
Research 121–150 of 596
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Mesothelial Stem Cells and Stromal Vascular Fraction for Skin Rejuvenation
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Construction of regulatory network for alopecia areata progression and identification of immune monitoring genes based on multiple machine-learning algorithms
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Metabolic syndrome in Iraqi patients with Alopecia areata: A case control study
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- Endocrinologia e Medicina Estética Ed. X
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Catechins-rich tea extract and its functional properties mitigating hair loss
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Secretome-Based Therapy Promotes Epidermal Thickness Recovery and Follicular Regrowth in Fluconazole-Induced Alopecia in Rats
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Evidence for the off-label use of tofacitinib in alopecia areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells